1. Home
  2. RFAI vs SENS Comparison

RFAI vs SENS Comparison

Compare RFAI & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RFAI
  • SENS
  • Stock Information
  • Founded
  • RFAI 2024
  • SENS 1996
  • Country
  • RFAI Singapore
  • SENS United States
  • Employees
  • RFAI N/A
  • SENS N/A
  • Industry
  • RFAI
  • SENS Industrial Machinery/Components
  • Sector
  • RFAI
  • SENS Industrials
  • Exchange
  • RFAI NYSE
  • SENS Nasdaq
  • Market Cap
  • RFAI 153.0M
  • SENS 179.7M
  • IPO Year
  • RFAI 2024
  • SENS N/A
  • Fundamental
  • Price
  • RFAI $10.25
  • SENS $0.85
  • Analyst Decision
  • RFAI
  • SENS Strong Buy
  • Analyst Count
  • RFAI 0
  • SENS 1
  • Target Price
  • RFAI N/A
  • SENS $2.00
  • AVG Volume (30 Days)
  • RFAI 19.6K
  • SENS 18.7M
  • Earning Date
  • RFAI 01-01-0001
  • SENS 02-27-2025
  • Dividend Yield
  • RFAI N/A
  • SENS N/A
  • EPS Growth
  • RFAI N/A
  • SENS N/A
  • EPS
  • RFAI N/A
  • SENS N/A
  • Revenue
  • RFAI N/A
  • SENS $22,205,000.00
  • Revenue This Year
  • RFAI N/A
  • SENS $0.12
  • Revenue Next Year
  • RFAI N/A
  • SENS $61.22
  • P/E Ratio
  • RFAI N/A
  • SENS N/A
  • Revenue Growth
  • RFAI N/A
  • SENS 11.41
  • 52 Week Low
  • RFAI $10.25
  • SENS $0.25
  • 52 Week High
  • RFAI $10.27
  • SENS $0.93
  • Technical
  • Relative Strength Index (RSI)
  • RFAI N/A
  • SENS 71.68
  • Support Level
  • RFAI N/A
  • SENS $0.67
  • Resistance Level
  • RFAI N/A
  • SENS $0.83
  • Average True Range (ATR)
  • RFAI 0.00
  • SENS 0.11
  • MACD
  • RFAI 0.00
  • SENS 0.03
  • Stochastic Oscillator
  • RFAI 0.00
  • SENS 83.71

About RFAI RF ACQUISITION CORP II

RF Acquisition Corp II is a blank check company.

About SENS Senseonics Holdings Inc.

Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.

Share on Social Networks: